| Literature DB >> 12669027 |
Donald M Coen1, Priscilla A Schaffer.
Abstract
In the absence of effective vaccines to control herpesvirus infections, nucleosidic antiviral drugs have been the mainstay of clinical treatment since their development in the late 1970s. However, given the drawbacks of these drugs, including the increasing emergence of drug-resistant clinical isolates, new strategies for treating herpesvirus infections are warranted. A range of promising new drugs with novel molecular targets has been developed, but will they cure latent infections?Entities:
Mesh：
Substances：
Year: 2003 PMID： 12669027 DOI： 10.1038/nrd1065
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694